Linda S May-Zhang, Ph.D, M.S.

Official Affiliation: Pharmacology

Profile

None provided

Publications

The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. Engineering the gut microbiota to treat chronic diseases. Dosoky NS, May-Zhang LS, Davies SS (2020) Appl Microbiol Biotechnol 104(18): 7657-7671
    › Primary publication · 32696297 (PubMed) · PMC7484268 (PubMed Central)
  2. Modified sites and functional consequences of 4-oxo-2-nonenal adducts in HDL that are elevated in familial hypercholesterolemia. May-Zhang LS, Yermalitsky V, Melchior JT, Morris J, Tallman KA, Borja MS, Pleasent T, Amarnath V, Song W, Yancey PG, Davidson WS, Linton MF, Davies SS (2019) J Biol Chem 294(50): 19022-19033
    › Primary publication · 31666337 (PubMed) · PMC6916491 (PubMed Central)
  3. Isolevuglandins as mediators of disease and the development of dicarbonyl scavengers as pharmaceutical interventions. Davies SS, May-Zhang LS, Boutaud O, Amarnath V, Kirabo A, Harrison DG (2020) Pharmacol Ther : 107418
    › Primary publication · 31629006 (PubMed) · PMC7495735 (PubMed Central)
  4. Administration of N-Acyl-Phosphatidylethanolamine Expressing Bacteria to Low Density Lipoprotein Receptor Mice Improves Indices of Cardiometabolic Disease. May-Zhang LS, Chen Z, Dosoky NS, Yancey PG, Boyd KL, Hasty AH, Linton MF, Davies SS (2019) Sci Rep 9(1): 420
    › Primary publication · 30674978 (PubMed) · PMC6344515 (PubMed Central)
  5. Isolevuglandins and cardiovascular disease. Davies SS, May-Zhang LS (2018) Prostaglandins Other Lipid Mediat : 29-35
    › Primary publication · 30296489 (PubMed) · PMC6555638 (PubMed Central)
  6. Modification by isolevuglandins, highly reactive γ-ketoaldehydes, deleteriously alters high-density lipoprotein structure and function. May-Zhang LS, Yermalitsky V, Huang J, Pleasent T, Borja MS, Oda MN, Jerome WG, Yancey PG, Linton MF, Davies SS (2018) J Biol Chem 293(24): 9176-9187
    › Primary publication · 29712723 (PubMed) · PMC6005447 (PubMed Central)
  7. Angiotensin receptor blocker vs ACE inhibitor effects on HDL functionality in patients on maintenance hemodialysis. Kaseda R, Tsuchida Y, Gamboa JL, Zhong J, Zhang L, Yang H, Dikalova A, Bian A, Davies S, Fogo AF, Linton MF, Brown NJ, Ikizler TA, Kon V (2018) Nutr Metab Cardiovasc Dis 28(6): 582-591
    › Primary publication · 29691148 (PubMed) · PMC5959764 (PubMed Central)
  8. Reactive Carbonyl Species Scavengers-Novel Therapeutic Approaches for Chronic Diseases. Davies SS, Zhang LS (2017) Curr Pharmacol Rep 3(2): 51-67
    › Primary publication · 28993795 (PubMed) · PMC5630168 (PubMed Central)
  9. Antibiotics Suppress Activation of Intestinal Mucosal Mast Cells and Reduce Dietary Lipid Absorption in Sprague-Dawley Rats. Sato H, Zhang LS, Martinez K, Chang EB, Yang Q, Wang F, Howles PN, Hokari R, Miura S, Tso P (2016) Gastroenterology 151(5): 923-932
    › Primary publication · 27436071 (PubMed) · PMC5391873 (PubMed Central)
  10. Microbial metabolism of dietary components to bioactive metabolites: opportunities for new therapeutic interventions. Zhang LS, Davies SS (2016) Genome Med 8(1): 46
    › Primary publication · 27102537 (PubMed) · PMC4840492 (PubMed Central)
  11. Apolipoprotein A-V is present in bile and its secretion increases with lipid absorption in Sprague-Dawley rats. Zhang LS, Sato H, Yang Q, Ryan RO, Wang DQ, Howles PN, Tso P (2015) Am J Physiol Gastrointest Liver Physiol 309(11): G918-25
    › Primary publication · 26505974 (PubMed) · PMC4669352 (PubMed Central)
  12. ABCG5/G8 deficiency in mice reduces dietary triacylglycerol and cholesterol transport into the lymph. Zhang LS, Xu M, Yang Q, Lou D, Howles PN, Tso P (2015) Lipids 50(4): 371-9
    › Primary publication · 25676339 (PubMed) · PMC4490865 (PubMed Central)
  13. Apolipoprotein A-V deficiency enhances chylomicron production in lymph fistula mice. Zhang LS, Xu M, Yang Q, Ryan RO, Howles P, Tso P (2015) Am J Physiol Gastrointest Liver Physiol 308(7): G634-42
    › Primary publication · 25617349 (PubMed) · PMC4385892 (PubMed Central)
  14. Biomimetic glycoliposomes as nanocarriers for targeting P-selectin on activated platelets. Zhu J, Xue J, Guo Z, Zhang L, Marchant RE (2007) Bioconjug Chem 18(5): 1366-9
    › Primary publication · 17691854 (PubMed)
  15. Biochemical characterization of the deafness-associated mitochondrial tRNASer(UCN) A7445G mutation in osteosarcoma cell cybrids. Li X, Zhang LS, Fischel-Ghodsian N, Guan MX (2005) Biochem Biophys Res Commun 328(2): 491-8
    › Primary publication · 15694374 (PubMed)
  16. Cloning and characterization of mouse mTERF encoding a mitochondrial transcriptional termination factor. Li X, Zhang LS, Guan MX (2005) Biochem Biophys Res Commun 326(2): 505-10
    › Primary publication · 15582606 (PubMed)
View full member profile

Featured Affiliation

View all affiliations

Contact Information

No address provided
5132573808 (p)
Email

Keywords & MeSH Terms

MeSH terms are retrieved from PubMed records. Learn more.

Key: MeSH Term Keyword

Amines Apolipoprotein A-II Apolipoprotein A-V Apolipoproteins Base Sequence Biological Transport Cells, Cultured Cholesterol, HDL Dietary Fats Drug Development Duodenum Gastrointestinal Tract Humans Intestinal Mucosa Lewis Blood Group Antigens Liposomes Lymphocytes Macrophages Mice Microbiota Nanoparticles Oxidative Stress Phospholipids Platelet Activation Point Mutation Postprandial Period Tennessee Translational Medical Research Tyrosine Up-Regulation